Publications by authors named "Toru Kanke"

Claim this Profile
P
Photoimmunotherapy targeting biliary-pancreatic cancer with humanized anti-TROP2 antibody.
Takashi Nishimura, Makoto Mitsunaga, Ryoichi Sawada, Masayuki Saruta, Hisataka Kobayashi, Toru Kanke

Cancer Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis.
Yoshikazu Hirose, Eiko Saijou, Yasuyoshi Sugano, Fumitaka Takeshita, Satoshi Nishimura, Toru Kanke

Proc Natl Acad Sci U S A· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling.
Fui Goon Goh, Pei Yuen Ng, Mary Nilsson, Toru Kanke, Robin Plevin

Br J Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of HMGB1 on ischemia-reperfusion injury in the rat heart.
Susumu Oozawa, Shuji Mori, Toru Kanke, Hideo Takahashi, Keyue Liu

Circ J· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of adenosine A2A receptor inhibits LPS-induced expression of intercellular adhesion molecule 1 and production of TNF-alpha in human peripheral blood mononuclear cells.
Ryosuke Hamano, Hideo Kohka Takahashi, Hiromi Iwagaki, Toru Kanke, Keyue Liu

Shock· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats.
Keyue Liu, Shuji Mori, Hideo K Takahashi, Yasuko Tomono, Hidenori Wake, Toru Kanke

FASEB J· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of adenosine receptor subtypes stimulation on mixed lymphocyte reaction.
Hideo Kohka Takahashi, Hiromi Iwagaki, Ryosuke Hamano, Toru Kanke, Keyue Liu

Eur J Pharmacol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction.
Hideo Kohka Takahashi, Hiromi Iwagaki, Takahito Yagi, Toru Kanke, Keyue Liu

Clin Immunol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenosine A2A-receptor stimulation inhibits lipopolysaccharide-induced interleukin-18 production in monocytes.
Hideo Kohka Takahashi, Toru Kanke, Keyue Liu, Tadashi Yoshino, Toshiaki Sendo

J Pharmacol Sci· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice.
Akira Yokoyama, Shuji Mori, Hideo K Takahashi, Toru Kanke, Hidenori Wake

Eur J Pharmacol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunosuppressive effects of nicotine during human mixed lymphocyte reaction.
Hideo K Takahashi, Hiromi Iwagaki, Ryosuke Hamano, Toru Kanke, Keyue Liu

Eur J Pharmacol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colonic hyperalgesia triggered by proteinase-activated receptor-2 in mice: involvement of endogenous bradykinin.
Atsufumi Kawabata, Naoyuki Kawao, Tomoko Kitano, Maho Matsunami, Reiko Satoh, Toru Kanke

Neurosci Lett· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice.
Atsufumi Kawabata, Maho Matsunami, Masahiro Tsutsumi, Tsuyoshi Ishiki, Osamu Fukushima, Toru Kanke

Br J Pharmacol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms for modulation of mouse gastrointestinal motility by proteinase-activated receptor (PAR)-1 and -2 in vitro.
Fumiko Sekiguchi, Naomi Hasegawa, Keiko Inoshita, Daiki Yonezawa, Naoki Inoi, Toru Kanke

Life Sci· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes.
Scott R Macfarlane, Callum M Sloss, Pamela Cameron, Toru Kanke, Roderick C McKenzie

Br J Pharmacol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2.
Toru Kanke, Hiroyuki Ishiwata, Mototsugu Kabeya, Masako Saka, Takeshi Doi

Br J Pharmacol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abrogation of bronchial eosinophilic inflammation and attenuated eotaxin content in protease-activated receptor 2-deficient mice.
Toshiaki Takizawa, Masaki Tamiya, Takuya Hara, Jiro Matsumoto, Naohiro Saito, Toru Kanke

J Pharmacol Sci· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2 as a potential therapeutic target.
Toru Kanke, Toshiaki Takizawa, Mototsugu Kabeya, Atsufumi Kawabata

J Pharmacol Sci· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice.
Atsufumi Kawabata, Yuko Oono, Daiki Yonezawa, Kaori Hiramatsu, Naoki Inoi, Toru Kanke

Br J Pharmacol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteinase-activated receptor-2-mediated relaxation in mouse tracheal and bronchial smooth muscle: signal transduction mechanisms and distinct agonist sensitivity.
Atsufumi Kawabata, Satoko Kubo, Tsuyoshi Ishiki, Naoyuki Kawao, Fumiko Sekiguchi, Toru Kanke

J Pharmacol Exp Ther· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of proteinase-activated receptor-2 (PAR-2) deletion on the pathophysiological changes produced by lipopolysaccharide in the mouse: comparison with dexamethasone.
Hamid Reza Kazerani, Robin Plevin, Junichi Kawagoe, Toru Kanke, Brian L Furman

J Pharm Pharmacol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo.
Atsufumi Kawabata, Toru Kanke, Daiki Yonezawa, Tsuyoshi Ishiki, Masako Saka

J Pharmacol Exp Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the C-terminal tail in protease-activated receptor-2-mediated Ca2+ signalling, proline-rich tyrosine kinase-2 activation, and mitogen-activated protein kinase activity.
Michael J Seatter, Robert Drummond, Toru Kanke, Scott R Macfarlane, Morley D Hollenberg

Cell Signal· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells.
Shigeru Morikawa, Wakako Takabe, Chikage Mataki, Toru Kanke, Takahiro Itoh

J Atheroscler Thromb· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential role for proteinase-activated receptor-2 in arthritis.
William R Ferrell, John C Lockhart, Elizabeth B Kelso, Lynette Dunning, Robin Plevin, Toru Kanke

J Clin Invest· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis